Posts by Nathan Lanclos

  LAFAYETTE, NY – January 24, 2024 – Ichor Life Sciences, a full-service, end-to-end contract research organization (CRO) and longevity biotechnology company, has set the stage for an exciting global advance in clinical trial services. Today, the company announced the expansion of Ichor Clinical’s services to Australia, Europe, and the United Kingdom.   Pioneering a forward-thinking approach to enhance accessibility to international research and strategy, Ichor Life Sciences is ensuring that biotechnology and pharmaceutical companies have access to a world of possibilities. Lisa Sonneborn, MA, LMHC, President of Ichor Clinical, stated, “Our mission is to act as a global catalyst, offering personalized global clinical trial services, strategy, and regulatory guidance to life sciences companies of all sizes, including small and medium-sized companies that require a superior level of service.”   Establishing collaborative processes and service offerings with concierge and boutique CROs in Australia, the UK, and Ireland, Ichor Clinical brings…

    LAFAYETTE, NY – November 14, 2023 – Ichor Life Sciences, a full-service contract research organization (CRO) and longevity biotechnology company, today announced the launch of Ichor Clinical Trial Services. With the founding of Ichor Clinical, the company is now able to serve biotechnology and pharmaceutical clients from early preclinical studies through late-stage clinical trials and FDA approval. Ichor Clinical offers a spectrum of customized clinical trial solutions, ranging from individual service options to full CRO assistance. Centered on solving each client’s unique challenges, the team specializes in critical areas such as protocol design, site identification and qualification, and recruitment and retention strategies. Ichor’s agile, relationship-focused approach allows the company to address complexities that may be difficult for larger, more standardized CROs, including assisting ongoing trials when they encounter enrollment hurdles or operational complications, restoring the trial’s trajectory toward success. Ichor’s preclinical offerings include protein services, pharmacology and discovery…